Hutchison China MediTech Limited (HCM) Insider Acquires £347,500 in Stock

Hutchison China MediTech Limited (LON:HCM) insider Karen Jean Ferrante acquired 10,000 shares of the company’s stock in a transaction dated Wednesday, August 2nd. The shares were bought at an average price of GBX 3,475 ($45.11) per share, for a total transaction of £347,500 ($451,122.94).

Shares of Hutchison China MediTech Limited (LON HCM) opened at 3775.00 on Friday. The stock’s 50 day moving average price is GBX 13,401.40 and its 200-day moving average price is GBX 5,601.24. The company’s market cap is GBX 2.29 billion. Hutchison China MediTech Limited has a 52 week low of GBX 1,760.00 and a 52 week high of GBX 372,000.00.

COPYRIGHT VIOLATION WARNING: “[[title]]” was first reported by [[site]] and is owned by of [[site]]. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at [[permalink]].

A number of brokerages have recently issued reports on HCM. Beaufort Securities reiterated a “buy” rating on shares of Hutchison China MediTech Limited in a research note on Tuesday, August 1st. Panmure Gordon reiterated a “buy” rating and set a GBX 3,530 ($45.83) price objective on shares of Hutchison China MediTech Limited in a research note on Thursday, June 22nd.

Hutchison China MediTech Limited Company Profile

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.